dc.contributor.author |
Brint, Elizabeth K. |
|
dc.contributor.author |
O'Callaghan, Grace |
|
dc.contributor.author |
Houston, Aileen M. |
|
dc.date.accessioned |
2013-07-31T09:50:16Z |
|
dc.date.available |
2014-11-01T05:00:05Z |
|
dc.date.issued |
2013-11-01 |
|
dc.identifier.citation |
Brint, E., O’Callaghan, G. and Houston, A. (2013) 'Life in the Fas lane: differential outcomes of Fas signaling', Cellular and Molecular Life Sciences, 70(21), pp. 4085-4099. doi: 10.1007/s00018-013-1327-z |
en |
dc.identifier.issn |
1420-9071 |
|
dc.identifier.uri |
http://hdl.handle.net/10468/1205 |
|
dc.identifier.doi |
10.1007/s00018-013-1327-z |
|
dc.description.abstract |
Fas, also known as CD95 or APO-1, is a member of the tumor necrosis factor/nerve growth factor superfamily. Although best characterized in terms of its apoptotic function, recent studies have identified several other cellular responses emanating from Fas. These responses include migration, invasion, inflammation, and proliferation. In this review, we focus on the diverse cellular outcomes of Fas signaling and the molecular switches identified to date that regulate its pro- and anti-apoptotic functions. Such switches occur at different levels of signal transduction, ranging from the receptor through to cross-talk with other signaling pathways. Factors identified to date including other extracellular signals, proteins recruited to the death-inducing signaling complex, and the availability of different intracellular components of signal transduction pathways. The success of therapeutically targeting Fas will require a better understanding of these pathways, as well as the regulatory mechanisms that determine cellular outcome following receptor activation. |
en |
dc.format.mimetype |
application/pdf |
en |
dc.language.iso |
en |
en |
dc.publisher |
Springer |
en |
dc.relation.uri |
http://link.springer.com/article/10.1007%2Fs00018-013-1327-z/fulltext.html |
|
dc.rights |
© Springer Basel 2013. The final publication is available at link.springer.com. |
en |
dc.subject |
Fas/CD95 |
en |
dc.subject |
DISC |
en |
dc.subject |
Apoptosis |
en |
dc.subject |
NF-κB |
en |
dc.subject |
Non-apoptotic |
en |
dc.subject |
Regulation |
en |
dc.title |
Life in the Fas lane: differential outcomes of Fas signalling |
en |
dc.type |
Article (peer-reviewed) |
en |
dc.internal.authorurl |
http://research.ucc.ie/profiles/C012/ahouston |
en |
dc.internal.authorcontactother |
Aileen Houston, Medicine Department , University College Cork, Cork, Ireland. +353-21-490-3000 Email: a.houston@ucc.ie |
en |
dc.internal.availability |
Full text available |
en |
dc.check.info |
Access to the full text restricted for 1 year by request of the publisher |
en |
dc.date.updated |
2013-07-03T08:31:52Z |
|
dc.description.version |
Accepted Version |
en |
dc.internal.rssid |
212807298 |
|
dc.contributor.funder |
Science Foundation Ireland
|
|
dc.description.status |
Peer reviewed |
en |
dc.identifier.journaltitle |
Cellular and Molecular Life Sciences : CMLS |
en |
dc.internal.copyrightchecked |
No |
en |
dc.internal.licenseacceptance |
Yes |
en |
dc.internal.IRISemailaddress |
a.houston@ucc.ie |
en |